HMOX1 and prostate carcinoma: Several studies using immunohistochemistry and quantitative RT-PCR have shown that HO-1 is expressed in prostate cancer cells, particularly in tumor cell nuclei, and this was found to be associated with high GS and poor outcome [22, 24–28].